$53.48Million | No. of Holdings #3
| Ticker | % Reduced |
|---|---|
| denali therapeutics inc | -56.79 |
| 8x8 inc new | -50.00 |
| sana biotechnology inc | -50.00 |
| Sector | % |
|---|---|
| Healthcare | 96.8 |
| Technology | 3.2 |
| Category | % |
|---|---|
| MID-CAP | 91.9 |
| SMALL-CAP | 4.9 |
| MICRO-CAP | 3.2 |
| Index | % |
|---|---|
| RUSSELL 2000 | 100 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Denali Therapeutics Inc Crestline Management, LP's holding in Denali Therapeutics Inc over time | 91.9% | 1,910,730 | $49.14M 91.9% | 56.79%decreased 56.79 percentreduced | |
8x8 Inc New 8x8 Inc NewEGHT Crestline Management, LP's holding in 8x8 Inc New over time | 3.17% | 990,850 | $1.69M 3.17% | 50%decreased 50 percentreduced | |
Sana Biotechnology Inc Crestline Management, LP's holding in Sana Biotechnology Inc over time | 4.93% | 755,736 | $2.64M 4.93% | 50%decreased 50 percentreduced | |